Milnacipran hcl
Milnacipran HCl is a generic prescription medication, available as oral tablets in strengths of 12.5 mg, 25 mg, 50 mg, and 100 mg. It works as a serotonin and norepinephrine reuptake inhibitor, commonly used to treat fibromyalgia and depression. Manufactured by Amneal Pharmaceuticals LLC, this product has been discontinued. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Milnacipran HCl is a generic prescription medication, available as oral tablets in strengths of 12.5 mg, 25 mg, 50 mg, and 100 mg. It works as a serotonin and norepinephrine reuptake inhibitor, commonly used to treat fibromyalgia and depression. Manufactured by Amneal Pharmaceuticals LLC, this product has been discontinued. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Milnacipran hcl",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Milnacipran hcl — ANDA 203308 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203308"
}
]
|
| identifier | ANDA203308 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"fda",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Milnacipran hcl |
